A012102: Multicancer Early Detection Blood Test Study — Building a National Reference Set to Validate Emerging Screening Technologies

Study Overview:
A012102 evaluates whether creating a large, national reference set of blood samples can help validate multicancer early detection (MCED) tests. These tests aim to detect cancers at earlier, more treatable stages across multiple tumor types, before symptoms appear.